In a significant move for the growing field of embedded health technology, The CareVoice, has announced securing $10 million in Series B financing. This financing round was led by the U.K.-based Apis Insurtech Fund I, which contributed substantially to the investment. The funding marks a pivotal moment for The CareVoice, propelling its total capital raised to approximately $20 million.

Since its inception, The CareVoice has swiftly emerged as a leader in the embedded health sector, offering innovative solutions that integrate health functionalities seamlessly into existing platforms. The company’s footprint now spans across 15 countries, showcasing its global impact and reach.

Unlike traditional approaches to health services, The CareVoice’s model focuses on embedding health functionalities into a single platform operated by service providers, particularly insurers. This approach caters to the growing demand for personalized health solutions and enhances customer experiences by integrating health services directly into their existing interactions.

One of The CareVoice’s notable achievements is its ability to weather the funding slowdown that affected many startups in the past year. By demonstrating healthy cash flow and doubling its revenues in 2023, the company showcased its resilience and growth potential. With projections indicating revenues of $10 million this year, The CareVoice is poised for further expansion and innovation in the embedded health sector.

CEO and co-founder Sebastien Gaudin highlighted The CareVoice’s commitment to efficiency and agility in delivering health tech solutions. He emphasized the company’s capability to bring the first version of a health tech solution live in as little as three months, significantly reducing time-to-market compared to traditional approaches.

With a dedicated team of around 40 employees, The CareVoice plans to utilize the fresh funding to expand its partnerships with insurers globally. Additionally, investments will be directed towards enhancing the next generation of CareVoiceOS, an operating system tailored for insurers, further solidifying its position as a leading provider of embedded health solutions.

As The CareVoice continues to revolutionize the healthcare landscape with its innovative offerings, the recent Series B financing underscores investor confidence in the company’s vision and potential for future growth.